+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Anxiety Disorders And Depression Treatment Market Analysis & Forecast 2024-2034: Market By Drug Class; By Indication; By Distribution Channel; and By Region

  • PDF Icon

    Report

  • 145 Pages
  • October 2023
  • Region: Global
  • Erevna Healthcare
  • ID: 5890395
The global anxiety disorders and depression treatment market size was estimated to be USD 21.56 billion in 2023 and is expected to reach at USD 41.83 billion by 2034 with a CAGR of 6.21% during the forecast period 2024-2034. Surge in prevalence of anxiety disorders & depression, growing awareness regarding the disorders among population, rising innovative product launches by key market players, increasing focus on development of novel therapies, growing investment for research by major market players, surge in novel drug approvals by regulatory bodies, and rising research & development activities for the development of innovative drugs for the treatment of anxiety & depression disorders are some of the key factors boosting the market growth.

Rising research & development activities for the development of innovative drugs for the treatment of anxiety & depression disorders is predicted to boost the market growth during the forecast period. For instance, in February 2022, AbbVie has sent an additional application to the US Food and Drug Administration (FDA) for the medication cariprazine (marketed as VRAYLAR). This application pertains to the use of cariprazine as an add-on treatment for individuals with major depressive disorder (MDD) who are already undergoing antidepressant therapy.

By drug class, antidepressants was the highest revenue-grossing segment in the global anxiety disorders and depression treatment market in 2023 owing to growing prevalence of major depressive disorder, increasing focus on manufacturing of advanced antidepressant drugs, and rising number of approvals for antidepressant drugs. For instance, in August 2022, Axsome Therapeutics has received approval from the US FDA for its product, Auvelity, designed to treat major depressive disorder in adults. This orally taken product operates through an innovative mechanism of action. Additionally, anxiolytics is predicted to grow at fastest CAGR during the forecast period owing surge in prevalence of mental cases, increasing investment in research & development activities, rising demand for novel therapies, and growing product approvals by regulatory bodies.

By indication, major depressive disorder (MDD) was the highest revenue-grossing segment in the global anxiety disorders and depression treatment market in 2023 owing to the growing prevalence of major depressive disorder, increasing product launches by major market players, and rising regulatory approvals. For instance, in February 2023, Biogen Inc. and Sage Therapeutics, Inc. have declared that the U.S. Food and Drug Administration (FDA) has acknowledged the submission of a New Drug Application (NDA) for zuranolone, intended for the treatment of major depressive disorder (MDD) and postpartum depression (PPD). Zuranolone is an experimental medication currently under assessment as a once-daily oral treatment with rapid effects over a 14-day period for adults dealing with MDD and PPD. Additionally, obsessive-compulsive disorder is predicted to grow at fastest CAGR during the forecast period owing growing demand for antidepressants, rising prevalence of mental illness, and increasing focus on development of innovative products.

By distribution channel, hospital pharmacies was the highest revenue-grossing segment in the global anxiety disorders and depression treatment market in 2023 owing to a rise in the number of patients seeking treatment & the sales of medications obtained by prescription for the treatment of MDD & other depressive disorders, increasing launch of new products by leading market players, and growing initiatives by major market players. For instance, in April 2023, A Phase 2/3 clinical trial to evaluate ulotaront has begun, according to Sunovion Pharmaceuticals Inc. (Sunovion) and Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka). The first patient has been chosen in the experiment. Ulotaront is a substance that also functions as a 5-HT1A agonist and activates the trace amine-associated receptor 1 (TAAR1). This study is focused on examining its potential for treating generalized anxiety disorder (GAD). Additionally, online pharmacies is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of anxiety, growing penetration of online pharmacies, and surge in number of internet users.

North America region is anticipated for the highest revenue share during the forecast period owing to the growing prevalence of anxiety & depression disorders, presence of major market players, increasing demand for antidepressant drugs, rising research & development activities, and surge in product approvals by regulatory bodies. For instance, in April 2023, VistaGen has unveiled fresh data, showcased at the 2023 Anxiety and Depression Association of America (ADAA) Conference, which provides additional validation for the suggested mechanism of action (MOA) of fasedienol (PH94B). This investigational pherine nasal spray is currently in Phase 3 development for addressing social anxiety disorder (SAD). Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of mental disorders, growing demand for advanced therapies, and increasing initiatives by leading market players. For instance, in February 2023, PureTech Health plc, a clinical-stage biopharmaceutical firm committed to transforming the approach to managing severe illnesses, has revealed its intention to progress with the development of LYT-300 (oral allopregnanolone) as a possible therapy for anxiety disorders and postpartum depression (PPD).

Segmentation: Anxiety Disorders And Depression Treatment Market Report 2022 - 2033

Anxiety Disorders And Depression Treatment Market Analysis & Forecast by Drug Class 2023 - 2034 (Revenue USD Bn)

  • Antidepressants
  • Anxiolytics
  • Anticonvulsants
  • Noradrenergic Agents
  • Atypical Antipsychotics

Anxiety Disorders And Depression Treatment Market Analysis & Forecast by Indication 2023 - 2034 (Revenue USD Bn)

  • Phobia
  • Major Depressive Disorder
  • Obsessive-Compulsive Disorder
  • Others

Anxiety Disorders And Depression Treatment Market Analysis & Forecast by Distribution Channel 2023 - 2034 (Revenue USD Bn)

  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies

Anxiety Disorders And Depression Treatment Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)

North America

  • U.S.
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Table of Contents

1. Research Methodology
1.1. Study Objectives
1.2. Study Scope
1.3. Research Assumptions
1.4. Research Framework
2. Introduction
2.1. Market Definition
2.2. Global Anxiety Disorders And Depression Treatment Market Overview
3. Executive Summary
4. Market Environment Analysis
4.1. Porter’s 5 Forces Analysis
4.2. PESTEL Analysis
4.3. SWOT Analysis
5. Market Dynamics
5.1. Drivers Analysis
5.2. Restraints Analysis
5.3. Opportunities Analysis
5.4. Threats Analysis
5.5. Trend Analysis
6. COVID-19 Impact Analysis
7. Anxiety Disorders And Depression Treatment Market: Drug Class Estimates & Trend Analysis
7.1. Drug Class Segment Opportunity Analysis
7.2. Antidepressants
7.2.1. Antidepressants Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.3. Anxiolytics
7.3.1. Anxiolytics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.4. Anticonvulsants
7.4.1. Anticonvulsants Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.5. Noradrenergic Agents
7.5.1. Noradrenergic Agents Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
7.6. Atypical Antipsychotics
7.6.1. Atypical Antipsychotics Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8. Anxiety Disorders And Depression Treatment Market: Indication Estimates & Trend Analysis
8.1. Indication Segment Opportunity Analysis
8.2. Phobia
8.2.1. Phobia Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.3. Major Depressive Disorder
8.3.1. Major Depressive Disorder Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.4. Obsessive-Compulsive Disorder
8.4.1. Obsessive-Compulsive Disorder Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
8.5. Others
8.5.1. Others Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9. Anxiety Disorders And Depression Treatment Market: Distribution Channel Estimates & Trend Analysis
9.1. Distribution Channel Segment Opportunity Analysis
9.2. Retail Pharmacies
9.2.1. Retail Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.3. Online Pharmacies
9.3.1. Online Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
9.4. Hospital Pharmacies
9.4.1. Hospital Pharmacies Market Analysis & Forecast, 2023-2034 (Revenue, USD Bn)
10. Regional Market Analysis
10.1. Regional Market Opportunity Analysis
11. North America Anxiety Disorders And Depression Treatment Market
11.1. North America Anxiety Disorders And Depression Treatment Market
11.1.1. North America Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.1.2. North America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
11.1.3. North America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.1.4. North America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.1.5. North America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.2. U.S. Global Anxiety Disorders And Depression Treatment Market
11.2.1. U.S. Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.2.2. U.S. Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.2.3. U.S. Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.2.4. U.S. Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
11.3. Canada Global Anxiety Disorders And Depression Treatment Market
11.3.1. Canada Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
11.3.2. Canada Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
11.3.3. Canada Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
11.3.4. Canada Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12. Europe Global Anxiety Disorders And Depression Treatment Market
12.1. Europe Global Anxiety Disorders And Depression Treatment Market
12.1.1. Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.1.2. Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
12.1.3. Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.1.4. Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.1.5. Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.2. Germany Global Anxiety Disorders And Depression Treatment Market
12.2.1. Germany Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.2.2. Germany Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.2.3. Germany Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.2.4. Germany Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.3. UK Global Anxiety Disorders And Depression Treatment Market
12.3.1. UK Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.3.2. UK Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.3.3. UK Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.3.4. UK Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.4. France Global Anxiety Disorders And Depression Treatment Market
12.4.1. France Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.4.2. France Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.4.3. France Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.4.4. France Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.5. Spain Global Anxiety Disorders And Depression Treatment Market
12.5.1. Spain Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.5.2. Spain Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.5.3. Spain Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.5.4. Spain Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.6. Italy Global Anxiety Disorders And Depression Treatment Market
12.6.1. Italy Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.6.2. Italy Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.6.3. Italy Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.6.4. Italy Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
12.7. Rest of Europe Global Anxiety Disorders And Depression Treatment Market
12.7.1. Rest of Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
12.7.2. Rest of Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
12.7.3. Rest of Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
12.7.4. Rest of Europe Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13. Asia Pacific Global Anxiety Disorders And Depression Treatment Market
13.1. Asia Pacific Global Anxiety Disorders And Depression Treatment Market
13.1.1. Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.1.2. Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
13.1.3. Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.1.4. Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.1.5. Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.2. Japan Global Anxiety Disorders And Depression Treatment Market
13.2.1. Japan Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.2.2. Japan Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.2.3. Japan Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.2.4. Japan Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.3. China Global Anxiety Disorders And Depression Treatment Market
13.3.1. China Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.3.2. China Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.3.3. China Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.3.4. China Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.4. India Global Anxiety Disorders And Depression Treatment Market
13.4.1. India Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.4.2. India Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.4.3. India Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.4.4. India Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.5. South Korea Global Anxiety Disorders And Depression Treatment Market
13.5.1. South Korea Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.5.2. South Korea Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.5.3. South Korea Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.5.4. South Korea Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.6. Australia Global Anxiety Disorders And Depression Treatment Market
13.6.1. Australia Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.6.2. Australia Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.6.3. Australia Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.6.4. Australia Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
13.7. Rest of Asia Pacific Global Anxiety Disorders And Depression Treatment Market
13.7.1. Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
13.7.2. Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
13.7.3. Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
13.7.4. Rest of Asia Pacific Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14. Latin America Global Anxiety Disorders And Depression Treatment Market
14.1. Latin America Global Anxiety Disorders And Depression Treatment Market
14.1.1. Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.1.2. Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
14.1.3. Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.1.4. Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.1.5. Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.2. Brazil Global Anxiety Disorders And Depression Treatment Market
14.2.1. Brazil Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.2.2. Brazil Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.2.3. Brazil Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.2.4. Brazil Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.3. Mexico Global Anxiety Disorders And Depression Treatment Market
14.3.1. Mexico Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.3.2. Mexico Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.3.3. Mexico Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.3.4. Mexico Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.4. Argentina Global Anxiety Disorders And Depression Treatment Market
14.4.1. Argentina Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.4.2. Argentina Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.4.3. Argentina Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.4.4. Argentina Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
14.5. Rest of Latin America Global Anxiety Disorders And Depression Treatment Market
14.5.1. Rest of Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
14.5.2. Rest of Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
14.5.3. Rest of Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
14.5.4. Rest of Latin America Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15. MEA Global Anxiety Disorders And Depression Treatment Market
15.1. MEA Global Anxiety Disorders And Depression Treatment Market
15.1.1. MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.1.2. MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, By Country, 2023-2034 (Revenue USD Bn)
15.1.3. MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.1.4. MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.1.5. MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.2. GCC Global Anxiety Disorders And Depression Treatment Market
15.2.1. GCC Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.2.2. GCC Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.2.3. GCC Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.2.4. GCC Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.3. South Africa Global Anxiety Disorders And Depression Treatment Market
15.3.1. South Africa Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.3.2. South Africa Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.3.3. South Africa Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.3.4. South Africa Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
15.4. Rest of MEA Global Anxiety Disorders And Depression Treatment Market
15.4.1. Rest of MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, 2023-2034 (Revenue USD Bn)
15.4.2. Rest of MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, By Drug Class, 2023-2034 (Revenue USD Bn)
15.4.3. Rest of MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, By Indication, 2023-2034 (Revenue USD Bn)
15.4.4. Rest of MEA Anxiety Disorders And Depression Treatment Market Size and Forecast, By Distribution Channel, 2023-2034 (Revenue USD Bn)
16. Competitor Analysis
16.1. Company Market Share Analysis, 2023
16.2. Major Recent Developments
17. Company Profiles
17.1. Axsome Therapeutics
17.2. Abbvie
17.3. Biogen Inc.
17.4. Bristol-Myers Squibb Company
17.5. Merck & Co. Inc
17.6. AstraZeneca
17.7. Eli Lily & Co
17.8. GlaxoSmithKline
17.9. Sage Therapeutics, Inc
17.10. H. Lundbeck A/S
17.11. Johnson & Johnson
17.12. Pfizer Inc
17.13. Dr. Reddy's Laboratory
17.14. Sanofi-Aventis
17.15. Forest Laboratories
17.16. Other Prominent Players
18. Conclusion19. Recommendations

Companies Mentioned

  • Axsome Therapeutics
  • Abbvie
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Merck & Co. Inc
  • AstraZeneca
  • Eli Lily & Co
  • GlaxoSmithKline
  • Sage Therapeutics Inc
  • H. Lundbeck A/S
  • Johnson & Johnson
  • Pfizer Inc
  • Dr. Reddy's Laboratory
  • Sanofi-Aventis
  • Forest Laboratories

Table Information